Ventana Biotech, Inc.

OTC: VNTA · Financial Services · Shell Companies

PublicHQ Denver, Reports USD

#1 of 1,015 Financial Services companies by revenue

EA Score

——

FH —DQ —GM —SS 22

v0.1 · 5/100 weight · pillars only

↑ listing tenure, market scale · ↓ workforce scale, market scale

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

Market cap

$90.9k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Ventana Biotech, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Financial Services

Nouveau Life Pharmaceuticals, Inc.——Ecrid, Inc.——Lotus Pharmaceuticals, Inc.——Blackhawk Growth Corp.——

Key facts

CEOJanne Christensen

SectorFinancial Services

IndustryShell Companies

HeadquartersDenver, null

ExchangeOTC: VNTA

Employees1

IPO date2009-09-08

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.